LifeStance Health Group Inc [LFST] stock prices are up 0.98% to $6.17 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LFST shares have gain 8.44% over the last week, with a monthly amount glided 2.15%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on January 03, 2024, when Barclays initiated its Underweight rating and assigned the stock a price target of $7. Previously, TD Cowen downgraded its rating to Market Perform on May 15, 2023, and elevated its price target to $9. On January 06, 2023, upgrade upgraded it’s rating to Overweight but maintained its price target of $8 on the stock. UBS downgraded its rating to a Neutral and reduced its price target to $10 on March 17, 2022. JP Morgan downgraded its rating to Neutral for this stock on November 09, 2021, and downed its price target to $12. In a note dated September 10, 2021, Cowen initiated an Outperform rating and provided a target price of $18 on this stock.
The stock price of LifeStance Health Group Inc [LFST] has been fluctuating between $4.74 and $9.59 over the past year. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $6.17 at the most recent close of the market.
Analyzing the LFST fundamentals
The LifeStance Health Group Inc [NASDAQ:LFST] reported sales of 1.06B for trailing twelve months, representing a surge of 22.34%. Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at -0.18%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.13 and Total Capital is -0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.98 points at the first support level, and at 5.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.28, and for the 2nd resistance point, it is at 6.39.
LifeStance Health Group Inc [LFST] reported earnings per share of -$0.12 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.09/share, meaning a difference of -$0.03 and a surprise factor of -33.30%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.17 per share as compared to estimates of -$0.08 per share, a difference of -$0.09 representing a surprise of -112.50%.
Ratios To Look Out For
It’s worth pointing out that LifeStance Health Group Inc [NASDAQ:LFST]’s Current Ratio is 1.11. As well, the Quick Ratio is 1.11, while the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 2.23, the price to book ratio is 1.64.
Transactions by insiders
Recent insider trading involved Qureshi Danish J.,, that happened on Apr 01 ’24 when 12965.0 shares were sold. Chief Digital Officer, Pantaleoni Pablo completed a deal on Apr 01 ’24 to sell 10116.0 shares. Meanwhile, Pardo Ryan sold 9830.0 shares on Apr 01 ’24.
